Workflow
和仁科技(300550) - 2017 Q3 - 季度财报
300550Heren Health(300550)2017-10-27 16:00

Financial Performance - Operating revenue for the period was ¥67,221,225.89, reflecting a 7.53% year-on-year growth[8] - Net profit attributable to shareholders decreased by 52.80% to ¥8,165,594.73 compared to the same period last year[8] - The net profit attributable to shareholders after deducting non-recurring gains and losses fell by 58.90% to ¥7,086,670.58[8] - Basic earnings per share decreased by 65.52% to ¥0.10[8] - The weighted average return on net assets was 1.67%, down by 5.52% year-on-year[8] - Net profit for the period was ¥9,532,962.74, a decrease from ¥16,444,238.99 in the same period last year[33] - The net profit attributable to the parent company was ¥8,165,594.73, down from ¥17,301,787.17 in the previous year[33] - Net profit for the period was ¥5,905,171.20, down 68.1% from ¥18,468,781.88 in the same period last year[38] - Operating profit decreased to ¥6,870,511.51, a decline of 63.3% from ¥18,703,794.99 in the previous year[38] - The company reported a total comprehensive income of ¥20,403,381.29, down 39.1% from ¥33,673,131.92 in the same period last year[42] Assets and Liabilities - Total assets increased to ¥643,100,698.93, representing a 9.19% increase compared to the end of the previous year[8] - Total assets increased to ¥630,747,828.30 from ¥579,357,378.09 at the beginning of the period[30] - Current assets totaled ¥444,808,841.61, compared to ¥401,003,068.11 at the start of the period, reflecting growth in liquidity[29] - The company reported a significant increase in accounts receivable, which rose to ¥237,687,415.96 from ¥148,818,359.30[28] - Total liabilities increased to ¥133,993,316.40 from ¥95,179,016.46, indicating a rise in financial obligations[30] - Cash and cash equivalents decreased by 52.07% to ¥61,799,529.78 from ¥128,929,938.28 due to longer project collection cycles[16] Cash Flow - Cash flow from operating activities showed a net outflow of ¥33,831,365.06, a decrease of 21.05% compared to the same period last year[8] - The net cash flow from operating activities was negative at CNY -33,831,365.06, improving from CNY -42,850,931.62 in the prior period[48] - Cash inflow from investment activities was CNY 620,503,300.39, significantly higher than CNY 188,539,332.30 in the previous period, marking a growth of 228.5%[49] - The net cash flow from investment activities was CNY -51,001,762.86, compared to a positive CNY 5,152,583.72 in the prior period[49] - Cash inflow from financing activities amounted to CNY 26,800,000.00, up from CNY 9,677,000.00, representing an increase of 176.5%[49] - The net cash flow from financing activities was CNY 17,532,984.67, a turnaround from CNY -984,900.44 in the previous period[49] Shareholder Information - The company reported a total of 14,628 common shareholders at the end of the reporting period[12] - The largest shareholder, Hangzhou Panyuan Investment Co., Ltd., holds 56.29% of the shares, with 45,030,000 shares pledged[12] - The company did not engage in any repurchase transactions among the top 10 shareholders during the reporting period[13] Expenses and Investments - Operating costs amounted to ¥58,987,136.31, up from ¥46,004,917.86 in the prior period, indicating a significant rise in expenses[32] - Sales expenses increased by 69.04% to ¥18,454,844.56, reflecting enhanced market development and marketing investments[16] - Investment income skyrocketed by 607.77% to ¥2,598,617.83, influenced by the purchase of bank wealth management products[16] - The company experienced an increase in asset impairment losses, which totaled ¥5,289,741.88, compared to ¥4,677,497.30 in the previous period[39] - Tax expenses for the period were ¥1,042,089.03, down from ¥2,268,563.59 in the same period last year[38]